Abbott launches dual-chamber pacemaker with first U.S. implants
November 7, 2023
The first U.S. commercial cases have been completed with the Abbott (NYSE: ABT)+
Aveir dual-chamber leadless pacemaker technology.
The first U.S. commercial cases have been completed with the Abbott (NYSE: ABT)+
Aveir dual-chamber leadless pacemaker technology.
ST. PAUL, Minn.–(BUSINESS WIRE)– Cardio Flow, Inc., a privately held commercial-stage medical device company and developer of minimally invasive devices to treat peripheral artery disease (PAD), is pleased to announce the successful completion of its first commercial cases for its FreedomFlow® Orbital Atherectomy Platform following FDA clearance in late September.
Levita Magnetics today announced the world’s first commercial use for its MARS magnetic-assisted robotic surgery platform.
While useful for killing pathogens including SARS-CoV-2, the lights may cause unwanted chemical reactions and should be used with ventilation, researchers say.
Proprio today announced the successful first-in-human use of its Paradigm surgical technology platform for 3D visualization.
Orthofix today announced it received FDA 510(k) clearance for its OsteoCove bioactive synthetic graft.
Moximed announced today that doctors completed the first commercial cases for its Misha knee system, an implantable shock absorber (ISA).